N/A
Completed N=10
Assessment of Limb Perfusion During Junctional Tourniquet
Source: ClinicalTrials.gov NCT02092415 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
May 2015
Primary outcomePrimary: Muscle Perfusion — 0.32; 0.10 IU/s
Summary
The goal of this study is to use contrast enhanced ultrasound to determine the degree to which flow is reduced during application of a junctional tourniquet (JT). Contrast enhanced ultrasound is performed to quantify thigh and calf perfusion at baseline and during application of the JT
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Muscle Perfusion |
0.32; 0.10 | — |
Eligibility Criteria
Inclusion Criteria
- Healthy subject
- Age 19-50
Exclusion Criteria
- Peripheral artery disease
- Known heart failure
- Right to left shunt
- Pregnancy
- Presence of femoral artery aneurysm
Data sourced from ClinicalTrials.gov (NCT02092415). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.